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Somatic cell nuclear transfer offers an alternative approach to the use of exogenous transcription factors for
the reprogramming of somatic cells. But is it a better way? Two groups have performed detailed molecular
comparisons between human cell lines made by the two methods and report different conclusions.Mouse embryonic stem cells (mESCs)
and induced pluripotent stem cells
(miPSCs) can, in the right circumstances,
form any cell type of the adult body. Their
human counterparts, hESCs and hiPSCs,
probably possess similar pluripotential
attributes although the range of tests
available to confirm this is circumscribed
by obvious ethical constraints. Both of
these human cell types have been feted
for their potential to provide new, in vitro
disease modeling modalities and replace-
ment tissues for sick human patients.
hiPSCs are considered by many to be
superior to hESCs because autologous
lines, as well as a broad range of dis-
ease-specific lines, can be prepared in
an ethically uncontentious manner. How-
ever, niggling questions remain as to their
functional and molecular similarity to
hESCs, a debate muddied by the genetic
diversity of the pluripotent lines being
compared. Unfortunately, in vitro fertiliza-
tion-derived hESCs (IVF-hESCs) and
hiPSC lines containing the same donor
genome (isogenic) are simply not avail-
able for comparison. However, recent
success in reprogramming somatic nuclei
by somatic cell nuclear transfer (SCNT)
(Tachibana et al., 2013) has allowed com-
parisons to be made between isogenic
NT-hESC and hiPSC lines using nonre-
lated IVF-hESC as a convenient reference
point.
In July this year, Ma et al. (2014) re-
ported that NT-hESCs made from fetal
fibroblast nuclei had transcriptional and
DNA methylation signatures much closer
to IVF-hESCs than did hiPSCs generated
from the same fibroblasts, leading the au-
thors to advocate the use of NT-hESCs
over hiPSCs. Similar findings have beenreported for mouse NT-ESCs and iPSCs
(Liang and Zhang 2013). In this issue of
Cell Stem Cell, Johannesson et al. (2014)
employ similar and new tests to examine
isogenic NT-hESC and hiPSC lines
made from neonatal and adult cell sour-
ces. Like Ma et al. (2014), they note that
both cell types display genetic and epige-
netic changes not seen in the somatic
donor populations. However, in contrast
to Ma et al. (2014), they find the scale
and nature of the epigenetic changes
similar for both cell types and conclude
that reprogramming per se, rather than
the exact method used, is responsible.
This is puzzling.
Both groups each analyzed two sets of
isogenic NT-hESC and hiPSC lines along-
side genetically unrelated IVF-hESC and
fibroblast somatic donor cells. Ma et al.
(2014) looked first for structural genome
changes and found on average 1.8, 0.8,
and 0.5 de novo copy number variations
(CNVs) in early-passage hiPSCs, NT-
hESCs, and IVF-hESCs, respectively.
These differences were not statistically
significant. Johannesson et al. (2014)
focused on nonstructural, coding muta-
tions and determined on average 10.57
and 10.43 de novo mutations in seven
NT-hESC and seven hiPSC lines derived
from neonatal foreskin and adult dermal
fibroblast somatic donors, respectively.
Again, these differences were not signifi-
cant. Most of the mutations were found
in lines derived from adult donors and
many were shared between indepen-
dently isolated lines, indicating they were
in the initial parental population as
shown previously (Gore et al., 2011).
When these data were augmented with
analysis from triploid NT-hESCs (NoggleCell Stem Cell 15,et al., 2011) and parthenogenetically
generated hESC lines, the authors
concluded that most mutations pre-ex-
isted in the donor cells or arose during
reprogramming rather than in postreprog-
ramming culture. However, the concor-
dance seen above between the groups
did not extend to the epigenetic changes
observed.
Differentiation proceeds by the estab-
lishment of epigenetic regulation of the
genome and involves covalent DNAmodi-
fication, particularly DNA methylation.
The methylation patterns of somatic and
embryonic genomes are clearly distinct
and these differences, inter alia, con-
tribute to the diagnostic transcriptomes
of every cell type and also underlie
imprinting phenomena where genes or
chromosomes (e.g., X inactivation) in-
herited from one of the parents are differ-
entially expressed in all fetal and adult
cells. Complete reprogramming demands
a resetting of the epigenetic landscape
and there have been many reports that
factor-mediated reprogramming is aber-
rant and incomplete and that iPSC lines
often retain an epigenetic memory of their
previous somatic state (Kim et al., 2010;
Liang and Zhang, 2013). Arguably, SCNT
mimics human physiology more faithfully
because it emulates normal fertilization
where the sperm genome has to be radi-
cally restructured; it is certainly faster.
Global DNA methylation patterns, tran-
scriptomes, and parental and X chromo-
some imprinting were therefore examined
by both groups. Ma et al. (2014) found that
the DNA methylation patterns of NT-
hESCs corresponded closely to those of
IVF-hESCs while hiPSC patterns differed
and retained 8-fold more sites indicativeNovember 6, 2014 ª2014 Elsevier Inc. 531
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sites reflective of random reprogramming
errors. In contrast, Johannesson et al.
(2014) found very little difference between
the global methylation patterns of hiPSCs,
NT-hESCs, and IVF-hESCs. Transcrip-
tome analysis performed by both groups
using RNA sequencing showed the
same trends as their global methylation
data, which is reassuring becausemethyl-
ation differences do not always lead to
transcriptional differences (Ma et al.,
2014). Finally, DNA methylation and tran-
scriptional analysis and the status of
imprinted loci, including X chromosomal
loci, were compared across the different
pluripotent cell lines. While both groups
found that aberrant sites were more
frequent in the NT-hESC and hiPSC lines,
Ma et al. (2014) again found the NT-
hESCs to have far fewer changes than
hiPSCs.
Setting aside limitations to interpreta-
tion posed by the small sample sizes
used, there are troublesome differences
between the two sets of data reported
above. Johannesson et al. (2014) flag
two potential causes: different somatic
cell donors (fetal versus neonatal and
adult) and different methods of factor-
mediated reprogramming (Sendai and
retrovirus versus mRNA). Regarding so-
matic donors, intuitively one expects fetal
donor nuclei to be more and not less sen-
sitive to exogenous stimuli than the older
sources. As for the reprogramming vec-532 Cell Stem Cell 15, November 6, 2014 ª2tors, the early reports of mRNA-mediated
reprogramming showed a much greater
concordance of transcriptional expres-
sion between IVF-hESCs and the mRNA-
hiPSCs than between IVF-hESCs and
retroviral hiPSCs (Warren et al., 2010). If
this proves to be the correct explanation,
then further analysis of SCNT-mediated
reprogramming may yield more insight
into the speed and efficiency of reprog-
ramming than into its quality (Shinagawa
et al., 2014). Of course, irrespective of
which explanation, if any, could reconcile
the results of the two studies, neither
paper addresses the issue of functional
similarity between NT-hESCs and
hiPSCs. This, as well as safety issues
(concerning therapeutic uses), is ulti-
mately what will determine whether a re-
programmed line is ‘‘fit for purpose.’’ It is
unclear whether reported genome-wide
transcriptional differences between the
various lines or epigenetic memory in
newly reprogrammed lines preclude their
usefulness for two reasons. The impact
of changes in transcriptional patterns on
the predisposition of pluripotent stem
cell lines to form particular lineages is
poorly understood and can be surpris-
ingly specific (Kim et al., 2011). Also,
epigenetic memory can be lost by
extended culture times (Liang and Zhang,
2013). Doubtless, functional readouts will
constitute the next phase of these
groundbreaking studies and the results
will be awaited with great interest.014 Elsevier Inc.REFERENCES
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